Press releases
May 10, 2021
Terasaki Institute Memorandum of Uderstanding
“The Terasaki Institute leads the world in the development of bioprintable, biopolymer-based technologies poised to revolutionize drug delivery, wearable and implantable devices. Jointly with HTL we expect to bring to life a new generation of biopolymer-based applications in critical sectors of precision and regenerative medicine,” added Maurizio Vecchione, Chief Innovation Officer of the Terasaki Institute for Biomedical Innovation.
Read more below.
To see our most recent news,
Read more
news from us
-
Articles April 16, 2024HTL Biotechnology at In-cosmetics Global Congress in Paris
As every year, the In-Cosmetics Global Congress returns to Paris, with top industry leaders and experts gathering under one roof.
This event promises opportunities and insights into the future of Cosmetics. -
Articles April 9, 2024France BioLead Membership
France BioLead structures, pilots, supports and promotes the French biomanufacturing sector.
-
Articles March 28, 2024Attending AMWC in Monaco
AMWC, the Aesthetic & Anti-Aging Medicine World Congress in Monaco.